Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
jinhua qinggan granules
- Development stage
- Phase 3
- Lead developer
- Beijing Xiehe Pharmaceutical
- Administration
- Oral
01
Overview
Jinhua Qinggan Granules (JHQG) is a Traditional Chinese Medicine (TCM) developed by Juxiechang (Beijing) Pharmaceutical for the treatment of viral respiratory infections. Originally formulated during the 2009 H1N1 influenza pandemic, it is composed of 12 herbal ingredients, including *Lonicera japonica* (honeysuckle) and *Gypsum fibrosum*. The drug is indicated for "Wind-Heat" syndrome, characterized by fever, sore throat, and cough. It has received approval in China for the treatment of influenza and mild-to-moderate COVID-19, and has been studied in international clinical trials for acute upper respiratory tract infections. The formulation is designed to clear heat and detoxify the lungs, exerting both anti-viral and anti-inflammatory effects.
- Brand names
- 金花清感颗粒Jinhua Qinggan Granules
- Other names
- JHQGJinhuaqinggan granules
02
Targets
IL-6 (Interleukin 6)IFNG (Interferon gamma)
Beyond the preview
Go deeper on jinhua qinggan granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on jinhua qinggan granules.